Cannabis in Switzerland

Last updated

Legality of cannabis in Europe .mw-parser-output .legend{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .legend-color{display:inline-block;min-width:1.25em;height:1.25em;line-height:1.25;margin:1px 0;text-align:center;border:1px solid black;background-color:transparent;color:black}.mw-parser-output .legend-text{} Legal for recreational use by adults Legal for medical use under certain conditions by adults Illegal Legality of Cannabis in Europe.svg
Legality of cannabis in Europe
  Legal for recreational use by adults
  Legal for medical use under certain conditions by adults
  Illegal

Legalisation booth in Zurich Legalize it zuerich.jpg
Legalisation booth in Zurich

Cannabis in Switzerland is illegal, though minor possession was decriminalised to a fine in 2012. Several cantons began to allow adults to cultivate and use cannabis in 2012, but this was struck down by federal courts. In 2016, four cities stated they were looking into establishing pilot cannabis clubs. The number of cannabis users in Switzerland is estimated to be around 500,000 among a population of 8 million. [1]

Contents

Classification

Cannabis that contains more than 1.0% THC is classified as an illegal drug in Switzerland. [2] Thus, according to the Federal Law on Drugs: the production, culture, use, and possession of cannabis, are all prohibited and considered as criminal infringements. [3] These infringements are punishable by up to three years of imprisonment and/or a fine.

Since 2017, legal cannabis, also known as "low-THC weed", with less than 1.0% of THC is sold at nearly every tobacco store. In March 2019, a Swiss Federal Administrative Court upheld the taxation scheme by customs officials, which impose a tax of CHF38 ($37.70) per kilo (2 lb) as well as 25% of the retail revenue. [4] CBD cannabis is commonly used in Switzerland, but a number of complications are present due to its cultivation, as law enforcement first has to determine whether the cannabis variety tests below 1% THC. If this is the case, the police is obliged to return confiscated cannabis material. For traffic infractions, it plays no role if CBD or THC cannabis is consumed. The THC level in legal CBD cannabis is high enough to render a drug test positive for THC, and therefore the driver will be prosecuted for driving under the influence of the drug. [5]

Medical use

Currently only one narcotic cannabis drug preparation is officially approved for medical use in Switzerland. [6] However, with the adoption of a revision in the Federal Act on Narcotics and Psychotropic Substances (NarcA), accepted by popular vote in 2008, and in effect since 2011, Swiss physicians can obtain a special permit from the Federal Office of Public Health for their patients with the allowance to prescribe medical cannabis for 12 months. Only two pharmacies in the country are permitted to dispense cannabis tinctures and cannabis oil concentrates for patients with serious or terminal illnesses. Treatment options with cannabis flower or cannabis resin are not available. [7]

An official cannabidiol preparation (Epidiolex) for rare forms of epilepsy was approved by the FDA in June 2018, and by the European Medicines Agency in September 2019. Since then, Swiss pharmacies are allowed to prepare and dispense medicinal products containing cannabidiol as a magistral formulation and prescription drug (not subject to the Narcotics Act), in accordance with current German Drug Codex DAC/NRF and Swiss pharmacopeial standards. [8]

Since August 1, 2022, the use of medical cannabis in Switzerland has been regulated under new legislation. Previously, Swiss physicians required a special permit from the Federal Office of Public Health (FOPH) to prescribe cannabis-based treatments. With the amendment of the Narcotics Act (Betäubungsmittelgesetz, BetmG), this requirement has been lifted. Doctors can now prescribe medical cannabis directly without prior authorization from the government. [9]

Medical cannabis is primarily used for chronic pain, spasticity associated with multiple sclerosis and neurological diseases, and nausea or appetite loss during chemotherapy. [10] However, its therapeutic benefits are still under scientific evaluation, and as a result, health insurance providers do not routinely cover costs for medical cannabis treatments. To improve scientific evidence, a mandatory data collection system has been implemented, requiring prescribing doctors to report treatment outcomes for at least two years. [11]

Access and Regulations Cannabis-based medicines, including tinctures and oil extracts, must be prescribed by a doctor and dispensed by a pharmacy. The cultivation, processing, and distribution of medical cannabis is regulated under Swissmedic, similar to other controlled substances such as morphine or methadone. [12] Although the recreational use of cannabis remains illegal, certain pilot projects are being conducted in Swiss cities to study the impact of controlled access to cannabis. [13]

Medical Cannabis and Telemedicine in Switzerland Since the legalization of medical cannabis, telemedicine services have become an important factor in improving patient access to cannabis-based treatments. Platforms like Canna Viva provide remote consultations with licensed physicians, allowing patients to receive medical advice and prescriptions online. This development is particularly relevant for patients in remote areas or those seeking specialized cannabis therapy guidance. [14]

Swiss authorities continue to monitor the therapeutic effects and prescription patterns of cannabis-based treatments through ongoing data collection and scientific evaluations.

Reform attempts

In 2001, the Swiss federal council committed to implement changes as to decriminalisation of personal use and possession, and the Parliament was tasked to tender concrete approaches.

An attempt to decriminalise possession and consumption of cannabis failed narrowly in Parliament in 2004. [15] As a reaction, a popular initiative ("Eidgenössische Volksinitiative für eine vernünftige Hanf-Politik mit wirksamem Jugendschutz") to amend the constitution to legalise cannabis was introduced 2004. [16]

A referendum was launched in 2008. [17] [18] Results from the November 2008 referendum showed 36.7% of those voting supported legalising cannabis. [16] [19]

Decriminalisation

Since 28 September 2012, the possession of less than 10 grams (⅓ oz) of cannabis was no longer a criminal infringement, but was still punished by a 100 Swiss francs flat fine. [20] Professional cannabis trade, as well as the possession of a quantity of cannabis that can affect the health of a large number of people (4 kg; 9 lb of hashish, according to the Federal Court [21] ), are punished by one to three years of imprisonment that can be augmented with a fine. [3]

In September 2017, the Federal Court ruled that the flat fine for the sole possession of small amounts has been applied incorrectly since 2013. Only the consumption of cannabis can be fined, not the possession by itself. [22] As a consequence, most cantonal police departments changed their policy towards stopping the prosecution of small amounts of cannabis, while others had already done so earlier. [23] However, the cantons of Geneva, Vaud, Valais, Neuchâtel, Jura, Ticino, St. Gallen and both Appenzell still retained their old policy. [24]

The Federal Court further decided in July 2023 that the sole possession of up to 10 grams (⅓ oz) of cannabis which is not meant for sale is completely legal and therefore the police cannot confiscate this amount. Nevertheless, the fine and confiscation is still due if consumption is present. [25]

With the exception of a few cannabis clubs in larger Swiss cities, requiring extensive bureaucratic paperwork to be a member, Cannabis consumers in Switzerland are relying on the black market to obtain cannabis. In 2023, synthetic cannabinoids have also been increasingly consumed in Switzerland, with detrimental health effects for the user. In Germany and other European countries, the growing of a limited amount of THC cannabis plants is legal, and cannabis up to 25g per person is no longer considered a narcotic in Germany. Switzerland has favoured criminal prosecution of natural cannabis cultivation, and invested very little expertise in the research of the drug. [26] [27] [28]

Canton legalisation and reversal

On 5 October 2012, the Federal Court invalidated the agreement on cannabis growing and trading that came into force on 1 January 2012, which allowed private citizens in the cantons of Geneva, Freiburg, Valais, Vaud, Neuchâtel, Basel-Stadt and Ticino to grow up to four cannabis plants (containing less than 1.0% of THC), for violating the federal law on drugs. [29]

Renewed legalisation attempts

On 11 September 2018, a parliamentary initiative by the Green Party, that demanded a law on regulation of cultivation, trade, recreational consumption, youth protection, and taxing of cannabis, was rejected in the National Council by 104 to 86 votes. [30] [31] Meanwhile the "Legalize It" organization is preparing a second popular initiative, originally set to launch in April 2018. [32] [ needs update ]

Pilot trials

In Switzerland, pilot trials for recreational cannabis dispensing are currently underway.

Genesis of the project

In 2016, the cities of Geneva, Basel, Bern, and Zürich stated that they planned to establish pilot cannabis clubs to gauge their utility, limited to 2,000 members total and to be studied for four years. [1] Those pilot projects have been shut down by the Federal Office of Public Health in November 2017 because of the lack of legal basis. In December 2017, an absolute majority of members of both parliamentary chambers signed a parliamentary motion to change the law. [33] However, in June 2018, the motion was narrowly rejected by the National Council after it had passed the Council of States. [34] In July 2018, the Federal Council sent a proposition for future cannabis studies to the parliament anyway. [35]

In 2019, Swiss parliament stopped a research project by the University of Bern that intended to make cannabis available for scientific studies. Particularly members of the conservative-right Swiss People’s Party and Centrists voted against the continuation of research in the field. In the meantime, registered cannabis preparations as well as the herb drug made it into mainstream medicine, and cannabis research has moved to the forefront of modern pharmacological research, particularly in the Americas and in countries with regulated, legal cannabis use. [36]

On 25 September 2020, the Swiss parliament approved an amendment to the Federal Act on Narcotics and Psychotropic Substances (NarcA), which came into effect on 15 May 2021. The amendment provides the legal basis for scientific trials with selected groups of recreational cannabis users residing in Switzerland, and establishes a federally regulated cultivation and harvesting process for narcotic cannabis with dosage/potency limitations (20% THC), limits for pesticide residues, and warning label requirements. Additives to cannabis products will also have to undergo federal approval, and need to be declared. Federal ordinances will remain in effect for 10 years, determining the individual criteria for trial participants, and regulating the national production and trade of psychotropic cannabis (made in Switzerland). [37]

In parallel, in October 2021, a parliamentary commission ruled cannabis should no longer be banned and Switzerland is going to draw up a draft law for the legalisation of cannabis "for better youth and consumer protection”. [38]

A number of larger Swiss cities and municipalities have expressed interest to participate in the pilot trials, but will have to prove first that recreational cannabis is not negatively affecting the well-being of the general population. Starting in 2022, approved Swiss cannabis users will have the opportunity to obtain cannabis at local pharmacies under these strict regulations set forth by the Federal Office of Public Health (FOPH). [39]

First pilot projects

The FOPH has authorised 19 April 2022 the first pilot test of an adult buyer program for recreational use of cannabis in Basel. This is expected to provide data on the way forward to regulate purchasing and consumption of recreationally used cannabis.

The program is expected to last 2 years and will include 400 adult volunteers who are to have their health monitored. The program, developed over the course of 6 years, was held up for legal reasons but the narcotics law was changed in 2021 and in August of that year was allowed to move forward.

Four cannabis strains will be made available, and two strains of hash will be available to a small group of approved volunteers in 10 pharmacies in Basel, produced by Pure Holding A.G. Participants of the program are to be warned not to share their cannabis with non-participants or they may be removed from the trial program. [40]

Originally scheduled to begin in September 2022, the "Weed Care" program started on 31 January 2023 with the possibility for a first half of the 374 participants to buy cannabis legally. [41] The study will last until March 2025 at least.

Penalties

The penalties imposed in practice also vary among cantons to a certain degree. The 2007 penalty guidelines adopted by the Bernse Judges' Association provide as follows: [42]

InfractionPenalty
Possession of less than 10 grams (⅓ oz) of cannabis not meant for saleno fine but confiscation of the drug. Depending on the canton, if use is present, a fine and registration of the user is imposed anyway.
Consumption of soft drugs in normal cases (first infraction, or minor quantity, or brief period of consumption)Fine of 100 CHF or more (depending on the accused's financial circumstances).
Consumption of soft drugs, repeated infractionsIncreasing fine or monetary penalty (depending on the severity of the infraction and the accused's financial circumstances).
Trade in soft drugs, up to 100 g (3½ oz)Monetary penalty of 1–5 daily rates. The daily rate is set by the court and usually amounts to roughly one thirtieth of the accused's monthly income. [43]
Trade in soft drugs, 100 g to 1 kg (3½ oz to 2 lb)Monetary penalty of 5–30 daily rates.
Trade in soft drugs, 1 kg (2 lb) or moreMonetary penalty of more than 30 daily rates.
Possession of more than 4 kg (9 lb)One to three years of imprisonment [3] [21]

See also

Related Research Articles

<span class="mw-page-title-main">Medical cannabis</span> Cannabis sativa L. (marijuana; hemp) used medicinally

Medical cannabis, medicinal cannabis or medical marijuana (MMJ) refers to cannabis products and cannabinoid molecules that are prescribed by physicians for their patients. The use of cannabis as medicine has a long history, but has not been as rigorously tested as other medicinal plants due to legal and governmental restrictions, resulting in limited clinical research to define the safety and efficacy of using cannabis to treat diseases.

<span class="mw-page-title-main">Cannabidiol</span> Phytocannabinoid discovered in 1940

Cannabidiol (CBD) is a phytocannabinoid, one of 113 identified cannabinoids in cannabis plants, along with tetrahydrocannabinol (THC), and accounts for up to 40% of the plant's extract. Medically, it is an anticonvulsant used to treat multiple forms of epilepsy. It was discovered in 1940 and, as of 2024 clinical research on CBD included studies related to the treatment of anxiety, addiction, psychosis, movement disorders, and pain, but there is insufficient high-quality evidence that CBD is effective for these conditions. CBD is sold as an herbal dietary supplement and promoted with yet unproven claims of particular therapeutic effects.

<span class="mw-page-title-main">Cannabis (drug)</span> Psychoactive drug from the cannabis plant

Cannabis, commonly known as marijuana, weed, and pot, among other names, is a non-chemically uniform drug from the cannabis plant. Native to Central or South Asia, the cannabis plant has been used as a drug for both recreational and entheogenic purposes and in various traditional medicines for centuries. Tetrahydrocannabinol (THC) is the main psychoactive component of cannabis, which is one of the 483 known compounds in the plant, including at least 65 other cannabinoids, such as cannabidiol (CBD). Cannabis can be used by smoking, vaporizing, within food, or as an extract.

<span class="mw-page-title-main">Legal history of cannabis in the United States</span>

In the United States, increased restrictions and labeling of cannabis as a poison began in many states from 1906 onward, and outright prohibitions began in the 1920s. By the mid-1930s cannabis was regulated as a drug in every state, including 35 states that adopted the Uniform State Narcotic Drug Act. The first national regulation was the Marihuana Tax Act of 1937.

Ten referendums were held in Switzerland during 2008. The first two were held on 24 February on business tax reform and aircraft noise. A further three were held on 1 June on public information campaigns, naturalisation and health reform. The final five were held on 30 November on legalising cannabis, making the pension age flexible, restricting the right of appeal of associations against construction projects, amending the constitutional article on narcotics and eliminating the statute of limitations with respect to pornographic crimes against children.

<span class="mw-page-title-main">Cannabis Social Club</span> Non-profit industry model for recreational cannabis

A Cannabis Social Club (CSC), sometimes called Cannabis Club, Cannabis Association, or Teapad, is a type of cannabis retail outlet, an industry model for regulated cannabis organised as non-profit cooperatives in which cannabis is cultivated, shared, and enjoyed collectively, usually for the purpose of relaxing or for social communion.

<span class="mw-page-title-main">Cannabis in the United States</span>

The use, sale, and possession of cannabis containing over 0.3% THC by dry weight in the United States, despite laws in many states permitting it under various circumstances, is illegal under federal law. As a Schedule I drug under the federal Controlled Substances Act (CSA) of 1970, cannabis containing over 0.3% THC by dry weight is considered to have "no accepted medical use" and a high potential for abuse and physical or psychological dependence. Cannabis use is illegal for any reason, with the exception of FDA-approved research programs. However, individual states have enacted legislation permitting exemptions for various uses, including medical, industrial, and recreational use.

<span class="mw-page-title-main">Synthetic cannabinoids</span> Designer drugs

Synthetic cannabinoids are a class of designer drug molecules that bind to the same receptors to which cannabinoids in cannabis plants attach. These novel psychoactive substances should not be confused with synthetic phytocannabinoids or synthetic endocannabinoids from which they are in many aspects distinct.

<span class="mw-page-title-main">Cannabis in Colorado</span>

In Colorado, cannabis has been legal for medical use since 2000 and for recreational use since late 2012. On November 7, 2000, 54% of Colorado voters approved Amendment 20, which amended the State Constitution to allow the use of marijuana in the state for approved patients with written medical consent. Under this law, patients may possess up to 2 ounces (57 g) of medical marijuana and may cultivate no more than six marijuana plants. Patients who were caught with more than this in their possession could argue "affirmative defense of medical necessity" but were not protected under state law with the rights of those who stayed within the guidelines set forth by the state. The Colorado Amendment 64, which was passed by voters on November 6, 2012, led to recreational legalization in December 2012 and state-licensed retail sales in January 2014. The policy has led to cannabis tourism. There are two sets of policies in Colorado relating to cannabis use: those for medicinal cannabis and for recreational drug use along with a third set of rules governing hemp.

The drug policy of Germany is considered to be one of the most lenient among European Union (EU) countries. Policies vary depending on the state.

<span class="mw-page-title-main">Legality of cannabis by U.S. jurisdiction</span>

In the United States, cannabis is legal in 39 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. Despite this prohibition, federal law is generally not enforced against the possession, cultivation, or intrastate distribution of cannabis in states where such activity has been legalized. Beginning in 2024, the Drug Enforcement Administration has initiated a review to potentially move cannabis to the less-restrictive Schedule III.

<span class="mw-page-title-main">Timeline of cannabis laws in the United States</span>

The legal history of cannabis in the United States began with state-level prohibition in the early 20th century, with the first major federal limitations occurring in 1937. Starting with Oregon in 1973, individual states began to liberalize cannabis laws through decriminalization. In 1996, California became the first state to legalize medical cannabis, sparking a trend that spread to a majority of states by 2016. In 2012, Washington and Colorado became the first states to legalize cannabis for recreational use.

<span class="mw-page-title-main">Cannabis in Iowa</span>

Cannabis in Iowa is illegal for recreational use if classified as marijuana but consumable hemp products including CBD products are legal for consumers to possess and registered retailers to sell. Possession of even small amounts of marijuana is a misdemeanor crime. The state has a medical program for patients with qualifying debilitating medical conditions that allows for the legal sale and possession of no more than 4.5g of THC per patient every 90-day period. Allowed modes of consumption are oral and topical forms including, but not limited to; tablets and tinctures, nebulizable inhalable forms, suppositories, and vaporization.

<span class="mw-page-title-main">Cannabis in Oklahoma</span>

Cannabis in Oklahoma is illegal for recreational use, but legal for medical use with a state-issued license, while CBD oil derived from industrial hemp is legal without a license.

<span class="mw-page-title-main">Cannabis retail outlet</span> Location at which marijuana is sold

A cannabis retail outlet is a location at which cannabis is sold or otherwise dispensed, either for recreational or for medical use.

<span class="mw-page-title-main">Cannabis in Austria</span>

Cannabis in Austria is legal for scientific and limited medical usage, but illegal for recreational usage. Possession of small amounts for personal use was decriminalized in 2016. The sale of cannabis seeds and plants is legal.

<span class="mw-page-title-main">Cannabis in Germany</span>

Cannabis in Germany has been legal for recreational usage by adults in a limited capacity since 1 April 2024, making it the ninth country in the world to legalise the drug. As of February 2024, it has been assessed that 4.5 million Germans use cannabis.

<span class="mw-page-title-main">Cannabis in Italy</span>

Cannabis is currently legal for medical and industrial uses in Italy, although it is strictly regulated, while it is decriminalized for recreational uses. In particular, the possession of small amounts of marijuana for personal use is a civil infraction. The possible sanctions for possession vary from the issuing of a diffida to first offenders, which is an injunction not to use the drug again; to the temporary suspension of certain personal documents for repeat offenders. Conversely, the unauthorized sale of cannabis-related products is illegal and punishable with imprisonment, as is the unlicensed cultivation of cannabis, although recent court cases have effectively established the legality of cultivating small amounts of cannabis for exclusively personal use. The licensed cultivation of cannabis for medical and industrial purposes requires the use of certified seeds; however, there is no need for authorization to plant certified seeds with minimal levels of psychoactive compounds.

<span class="mw-page-title-main">Cannabis in Luxembourg</span>

Cannabis in Luxembourg is legal for recreational and medical use for adults under specific circumstances. A bill was passed in the country's parliament June 2023 to legalise the following for adults in Luxembourg: recreational possession, home-use of cannabis, and growing up to four cannabis plants per household. The law took effect on 21 July 2023.

<span class="mw-page-title-main">Cannabis in Thailand</span> Laws and regulations of cannabis in Thailand

In Thailand, cannabis, known by the name Ganja has recently had new laws passed through. Cannabis that has less than 0.2% THC, referred to as industrial hemp in the USA, was legalised on 9 June 2022. Medicinal cannabis, with no THC restrictions, was made legal in 2018 but required patients to obtain a prescription from a medical practitioner. Recreational cannabis is still illegal according to Thai law.

References

  1. 1 2 "'Cannabis clubs' set for four Swiss cities - The Local". Thelocal.ch. 18 November 2016. Retrieved 23 November 2016.
  2. ↑ See the Interior Department Edict on Drugs 30/05/2011
  3. 1 2 3 "RS 812.121 Loi fédérale du 3 octobre 1951 sur les stupéfiants et les substances psychotropes (Loi sur les stupéfiants, LStup)". Admin.ch. Retrieved 16 November 2016.
  4. ↑ "THC-lite:Court confirms legal weed should be taxed as tobacco". swissinfo.ch. Retrieved 16 July 2019.
  5. ↑ "Using CBD and driving: should you choose?" naturalpes.ch. Retrieved 9 January 2024.
  6. ↑ Zulassung Sativex®, Spray zur Anwendung in der Mundhöhle (cannabis sativae folii cum flore extractum spissum) swissmedic.ch. 11-02-2013. Retrieved 20 November 2018.
  7. ↑ Medizinal-Cannabis Schweiz Archived 30 December 2021 at the Wayback Machine . Retrieved 20 November 2018.
  8. ↑ Products containing cannabidiol (CBD) Overview and implementation guide 05.07.2019 (third updated version). swissmedic.ch. Retrieved 25 September 2019.
  9. ↑ Swiss Federal Office of Public Health - Medical Cannabis in Switzerland
  10. ↑ Swiss Federal Office of Public Health - Law Changes on Medical Cannabis
  11. ↑ Swiss Federal Office of Public Health - Medical Cannabis in Switzerland
  12. ↑ Swissmedic - Medical Cannabis Regulation
  13. ↑ Swiss Federal Office of Public Health - Pilot Studies on Cannabis
  14. ↑ Canna Viva - Swiss Telemedicine Platform for Medical Cannabis
  15. ↑ See documentation available under docket no. 01.024 Archived 2008-01-15 at the Wayback Machine on the Parliament website.
  16. 1 2 Eidgenössische Volksinitiative 'für eine vernünftige Hanf-Politik mit wirksamem Jugendschutz', admin.ch – Swiss government, for results see: "Abstimmung Nr. 538". Retrieved 2013-09-05.
  17. ↑ Bundesgesetz vom 3. Oktober 1951 über die Betäubungsmittel und die psychotropen Stoffe (Betäubungsmittelgesetz, BetmG), Admin.ch, 12 June 1981, retrieved 17 February 2011
  18. ↑ de:Eidgenössische Volksinitiative "für eine vernünftige Hanf-Politik mit wirksamem Jugendschutz"
  19. ↑ "Swiss approve prescription heroin". BBC News Online. 30 November 2008. Retrieved 30 November 2008.
  20. ↑ "FF 2012 7539" (PDF). Retrieved 16 November 2016.
  21. 1 2 Cf. the Federal Court judgement ATF 109 IV 143
  22. ↑ Michael Knodt (21 September 2017), Swiss Federal Court Okays 10g of Cannabis, Marijuana.com, retrieved 30 December 2017
  23. ↑ Glarus und Graubünden werden bei Hanfbesitz lockerer (in German), Suedostschweiz.ch, 29 September 2017, retrieved 30 December 2017
  24. ↑ Kantönligeist in der Cannabis-Politik (in German), Blick.ch, 13 February 2018, retrieved 24 February 2018
  25. ↑ Cannabis: bis 10 Gramm Eigenkonsum keine Beschlagnahmung möglich (in German), SRG SSR, 24 July 2023, retrieved 28 July 2023
  26. ↑ "Crisis on Zurich’s weed market" hellozurich.ch. Retrieved 9. Jan. 2034.
  27. ↑ "Luxemburg legalisiert privaten Anbau und Konsum von Cannabis" (in German) zeit.de. Retrieved 9. Jan 2024.
  28. ↑ "German cabinet OKs landmark bill over legal cannabis use" Reuters. Retrieved 9 Jan. 2024.
  29. ↑ "Justice: Le TF annule le concordat latin sur la culture du chanvre - Suisse". Le Matin. lematin.ch. 5 October 2012. Retrieved 16 November 2016.
  30. ↑ "Cannabis, Einbürgerung, Führerausweisentzug: Das hat der Nationalrat beschlossen" (in German). aargauerzeitung.ch. 11 September 2018. Archived from the original on 14 September 2018. Retrieved 14 September 2018.
  31. ↑ "Bundesgesetz zur Hanfregulierung (neues Schweizer Hanfgesetz)" (in German). Archived from the original on 23 December 2019. Retrieved 14 September 2018.
  32. ↑ "Hanfgesetz ist im Nationalrat chancenlos" (in German). blick.ch. 11 September 2018. Retrieved 14 September 2018.
  33. ↑ "Im Bundeshaus startet die grosse Cannabis-Offensive" (in German). AargauerZeitung.ch. 14 December 2017. Archived from the original on 30 December 2017. Retrieved 30 December 2017.
  34. ↑ Rüdiger, Esthy (11 June 2018). "Der Nationalrat sagt Nein zu Cannabis-Studien – das würden sie für die Schweiz bedeuten". Neue Zürcher Zeitung (in German). Retrieved 14 September 2018.
  35. ↑ "Bundesrat will Cannabis-Pilotversuche ermöglichen". Neue Zürcher Zeitung (in German). 4 July 2018. Retrieved 14 September 2018.
  36. ↑ "No cannabis for scientific studies, says Swiss parliament" swissinfo. Retrieved 9 January 2024.
  37. ↑ Pilot trials with cannabis Federal Office of Public Health. bag.admin.ch. Retrieved 30 July 2021.
  38. ↑ "Switzerland to legalise recreational and medical cannabis usage". The Local Switzerland. 19 October 2021. Retrieved 23 October 2021.
  39. ↑ Kurz Z (27.01.2021) "Legaler Verkauf von Cannabis in Schweizer Apotheken" (in German) Pharmazeutische Zeitung.de. Retrieved 30 July 2021.
  40. ↑ "Switzerland To Launch Adult-Use Cannabis Sale Trial Program This Summer". The Local Switzerland. 5 May 2022. Retrieved 5 May 2022.
  41. ↑ "For the first time in Switzerland, few selected people can legally buy cannabis for recreational use as part of a study". 30 January 2023.
  42. ↑ Verband Bernischer Richter und Richterinnen (VBR) / Association des juges bernois (AJB) (1 January 2007). Richtlinien für die Strafzumessung (in German) (2 / 2006 ed.). p. 27.
  43. ↑ Annex to the Guidelines, op.cit., p. 3.

[1]

  1. ↑ "Testsieger für Hanföle in der Schweiz". Vaporspirit (in German). Retrieved 24 December 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.